Related Experiment Video
Updated: Dec 15, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
The GABAB Receptor-Structure, Ligand Binding and Drug Development.
Linn Samira Mari Evenseth1, Mari Gabrielsen1, Ingebrigt Sylte1
1Molecular Pharmacology and Toxicology, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, NO-9037 Tromsø, Norway.
The gamma-aminobutyric acid type B receptor (GABAB-R) is crucial for central nervous system inhibition. This review explores its structure, function, and potential for developing new drugs targeting various disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- The gamma-aminobutyric acid type B receptor (GABAB-R) is a G-protein coupled receptor (GPCR) vital for neurotransmission in the central nervous system (CNS).
- GABAB-R dysfunction is implicated in neurological and psychiatric disorders such as anxiety, depression, addiction, and cancer.
- Despite its importance, few clinically approved drugs target GABAB-R, with baclofen being the sole agonist.
Purpose of the Study:
- To review the current understanding of GABAB-R structure and activation mechanisms.
- To summarize known compounds targeting GABAB-R.
- To highlight the receptor's significance in current and future drug design and discovery efforts.
Main Methods:
- Literature review of existing research on GABAB-R.
- Analysis of structural and functional data related to GABAB-R subunits (GABAB1 and GABAB2).
- Examination of known agonists and antagonists and their mechanisms.
Main Results:
- GABAB-R is a mandatory heterodimer comprising GABAB1 and GABAB2 subunits, each with distinct domains (Venus Flytrap and 7TM).
- The receptor plays a critical role in mediating GABA's inhibitory neurotransmission.
- Limited therapeutic agents currently target this receptor, underscoring a gap in treatment options.
Conclusions:
- GABAB-R represents a promising target for therapeutic intervention in a range of disorders.
- Further research into GABAB-R structure and pharmacology is essential for novel drug development.
- Understanding the receptor's mechanisms can unlock new strategies for treating CNS-related conditions.
More Related Videos
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
11:57Using an α-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking
Published on: March 28, 2014
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
G-protein Coupled Receptors
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...